AMA
Elradi M, Darwish A, Hoseiny HA. Serum Chemerin Level as a Potential Biomarker of Early Cardiac Involvement in Patients with Psoriasis: a Case-Control Study. Dermatology Review/Przegląd Dermatologiczny. 2026;113(2):67-73. doi:10.5114/dr.2026.163265.
APA
Elradi, M., Darwish, A., & Hoseiny, H. A. (2026). Serum Chemerin Level as a Potential Biomarker of Early Cardiac Involvement in Patients with Psoriasis: a Case-Control Study. Dermatology Review/Przegląd Dermatologiczny, 113(2), 67-73. https://doi.org/10.5114/dr.2026.163265
Chicago
Elradi, Mona, Ahmed Darwish, and Heba A Hoseiny. 2026. "Serum Chemerin Level as a Potential Biomarker of Early Cardiac Involvement in Patients with Psoriasis: a Case-Control Study". Dermatology Review/Przegląd Dermatologiczny 113 (2): 67-73. doi:10.5114/dr.2026.163265.
Harvard
Elradi, M., Darwish, A., and Hoseiny, H. (2026). Serum Chemerin Level as a Potential Biomarker of Early Cardiac Involvement in Patients with Psoriasis: a Case-Control Study. Dermatology Review/Przegląd Dermatologiczny, 113(2), pp.67-73. https://doi.org/10.5114/dr.2026.163265
MLA
Elradi, Mona et al. "Serum Chemerin Level as a Potential Biomarker of Early Cardiac Involvement in Patients with Psoriasis: a Case-Control Study." Dermatology Review/Przegląd Dermatologiczny, vol. 113, no. 2, 2026, pp. 67-73. doi:10.5114/dr.2026.163265.
Vancouver
Elradi M, Darwish A, Hoseiny H. Serum Chemerin Level as a Potential Biomarker of Early Cardiac Involvement in Patients with Psoriasis: a Case-Control Study. Dermatology Review/Przegląd Dermatologiczny. 2026;113(2):67-73. doi:10.5114/dr.2026.163265.
